DETERMINE-preserved - Dapagliflozin Effect on Exercise Capacity Using a 6-minute Walk Test in Patients With Heart Failure With Preserved Ejection Fraction

NCT03877224 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

504

Enrollment

INDUSTRY

Sponsor class

Conditions

Heart Failure With Preserved Ejection Fraction (HFpEF)

Interventions

DRUG: Dapagliflozin
OTHER: Placebo

Sponsor

AstraZeneca